Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
30,58 USD | -0,57% | +7,40% | -17,36% |
Vakgebied
Aantal werknemers: 919
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Next Generation Sequencing Tools
50,5
%
| 99 | 48,8 % | 124 | 50,5 % | +24,56% |
Synthetic Genes
30,0
%
| 62 | 30,2 % | 74 | 30,0 % | +19,56% |
Antibody Discovery
9,5
%
| 24 | 11,9 % | 23 | 9,5 % | -4,13% |
Oligo Pools
5,9
%
| 12 | 6,1 % | 14 | 5,9 % | +16,62% |
DNA Libraries
4,2
%
| 6 | 3,0 % | 10 | 4,2 % | +65,90% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Americas
61,7
%
| 122 | 60,2 % | 151 | 61,7 % | +23,51% |
EMEA
29,1
%
| 62 | 30,5 % | 71 | 29,1 % | +15,00% |
APAC
9,2
%
| 19 | 9,3 % | 22 | 9,2 % | +18,11% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 04-02-13 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 01-04-13 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | 05/01 |
Patrick Finn
PSD | President | 53 | 03-02-15 |
Chet Gandhi
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-23 |
Chief Tech/Sci/R&D Officer | - | 01-03-14 | |
Siyuan Chen
CTO | Chief Tech/Sci/R&D Officer | - | 01-12-20 |
Aaron Sato
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dennis Cho
CMP | Compliance Officer | 53 | 27-09-21 |
Angela Bitting
IRC | Investor Relations Contact | - | 01-11-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 01-11-16 |
Jan Johannessen
BRD | Director/Board Member | 67 | 01-10-18 |
Keith Crandell
BRD | Director/Board Member | 63 | 01-10-13 |
Robert Chess
BRD | Director/Board Member | 66 | 01-06-14 |
Nelson Chan
BRD | Director/Board Member | 62 | 01-05-19 |
William Banyai
FOU | Founder | 69 | 04-02-13 |
Director/Board Member | 58 | 06-08-21 | |
Emily Leproust
CEO | Chief Executive Officer | 50 | 01-04-13 |
Xiaoying Mai
BRD | Director/Board Member | 36 | 01-07-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 818 022 | 56 786 314 ( 98,22 %) | 0 | 98,22 % |
Bedrijfsgegevens
Twist Bioscience Corp.
681 Gateway Boulevard
94080, San Francisco
+800 719 0671
http://www.twistbioscience.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-17,36% | 1,78 mld. | |
-2,86% | 87,31 mld. | |
+2,63% | 40,86 mld. | |
-22,48% | 29,36 mld. | |
+58,56% | 24,49 mld. | |
-14,33% | 17,31 mld. | |
-18,70% | 11,62 mld. | |
-15,61% | 11,31 mld. | |
-44,02% | 11,26 mld. | |
+5,17% | 8,31 mld. |
- Beurs
- Aandelen
- Koers TWST
- Onderneming Twist Bioscience Corporation